Oops! Something went wrong, please try again later.
Sagimet is a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors that are designed to target dysfunctional …
AdSeeking Alpha Has the Analysis You Need to Make Smarter Investing Decisions. Take advantage of potential growth with timely investment data and analysis.
Compare Your Stocks · Independent Authors · Alpha Picks · Invest with Confidence
Save
Share
More